XPHARM
Pharmaceutical products for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products containing fatty acid blends for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products for the treatment of lipid imbalances; pharmaceutical products for the treatment of sickle cell disease
Pending · February 26, 2025 · 99057385 ·